The survival analysis (5-year follow-up of 106 colon cancer patients) showed that the median survival rate of patients with LEF1 expressed tumor was 48.5 months, which was significantly poorer than those with LEF1-negative tumors (more than 60 months) (P<0.05; Figure 1B). Here, LEF1 is linked to colonic neoplasm.